Scully Scott Murphy & Presser
Therapeutic use of bone morphogenetic proteins
The invention relates to a polypeptide selected from bone morphogenetic protein 10 (BMP10), or a bone morphogenetic protein 9 (BMP9) variant lacking osteogenic activity, for use in the treatment of a vascular disease or a respiratory disease. The invention also relates to novel BMP9 variants and to pharmaceutical compositions comprising said polypeptides.
CAMBRIDGE ENTERPRISE LIMITED
A A A A C A A A A A A
A61P A61K A61K A61P C07K A61K A61P A61P A61P A61K A61P
inventional inventional additional inventional inventional inventional inventional inventional inventional additional inventional
Paul D Nicholas W. Wei
Upton Morrell Li